Atrium Therapeutics, Inc.
← Back to RNA Overview

Atrium Therapeutics, Inc. (RNA)

Profitability & Net Margin History

Current Net Margin

-5595.93%

Atrium Therapeutics, Inc. currently has a net profit margin of -5595.93%.

Financial Fundamentals

RNAQuarterly Data • 5Y View

Historical Margin Data

DateRev ($B)NI ($B)Net MarginChange (bps)
2025-12-310.00-0.05-5595.93%

* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.